Specialty Enzymes Market Report 2023: Investments By Various Multinational Enzyme Manufacturers Bolster Sector
April 19, 2023 04:23 ET
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Specialty Enzymes Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Proteases, Polymerases &...
Diagnostic Enzyme Global Market Report 2023: Sector to Reach $4.75 Billion by 2026 at a CAGR of 5.7%
March 27, 2023 10:03 ET
|
Research and Markets
Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Diagnostic Enzyme Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This reportprovides strategists, marketers...
Global Diagnostic Specialty Enzymes Market to Reach $1.22 Billion by 2027 at a CAGR 8.1%
September 16, 2022 04:18 ET
|
Research and Markets
Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Diagnostic Specialty Enzymes Market (2022-2027) by Type, Application, Source, Form, and Geography, with Competitive Analysis, Impact of...
The Worldwide Enzymes Industry is Expected to Reach $19.2 Billion by 2031
June 29, 2022 05:48 ET
|
Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Enzymes Market 2021-2031 by Product Type, Source, Reaction Type, Application, and Region: Trend Forecast and Growth Opportunity" report has been...
Global Gene Editing Beyond CRISPR Market (2022 to 2035) - Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies
March 22, 2022 06:13 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies:...
Global Specialty Enzymes Market (2021 to 2030) - Featuring BASF, Novozymes and Codexis Among Others
February 22, 2022 05:28 ET
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Specialty Enzymes"report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with...
Global Industrial Enzymes Market, 2021-2026 - Demand for Natural Substitutes of Synthetic Chemicals and Development of Enzymes with a Longer Shelf-Life Creates Opportunities
February 11, 2022 07:03 ET
|
Research and Markets
Dublin, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The "Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Food & Beverages, Bioethanol,...
Global Diagnostic Enzyme Market (2021 to 2030) - Featuring Genzyme, Roche and Codexis Among Others
December 30, 2021 06:33 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Diagnostic Enzyme Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9
November 10, 2021 07:30 ET
|
Exavir Therapeutics
Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...
Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV
September 16, 2021 07:30 ET
|
Exavir Therapeutics
With a single administration, XVIR-210, a nano-formulated prodrug of tenofovir, provided drug levels sufficient for chronic HBV treatment, HIV treatment, and HIV prophylaxis for over two months in...